Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION …
{{id}} {{{paragraph}}}
Example: bachelor of science
HIGHLIGHTS OF PRESCRIBING INFORMATION …
1. HIGHLIGHTS OF PRESCRIBING INFORMATION Hypoglycemia: May be life-threatening. Increase frequency of These HIGHLIGHTS do not include all the INFORMATION needed to use glucose monitoring with changes to: insulin dosage, BASAGLAR safely and effectively. See full PRESCRIBING co-administered glucose lowering medications, meal pattern, INFORMATION for BASAGLAR physical activity; and in patients with renal or hepatic impairment and hypoglycemia unawareness. ( , ). BASAGLAR (insulin glargine injection), for subcutaneous use Medication Errors: Accidental mix-ups between insulin products Initial Approval: 2000 can occur.
diabetes, in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta-blockers) [see Drug Interactions (7)], or in patients who experience recurrent hypoglycemia. Risk Factors for Hypoglycemia
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: